On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened lower -7.65% from the last session, before settling in for the closing price of $7.97. Price fluctuations for CAPR have ranged from $5.68 to $23.40 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 11.01% over the last five years. Company’s average yearly earnings per share was noted -84.96% at the time writing. With a float of $40.16 million, this company’s outstanding shares have now reached $45.71 million.
Capricor Therapeutics Inc (CAPR) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Capricor Therapeutics Inc is 12.17%, while institutional ownership is 36.36%.
Capricor Therapeutics Inc (CAPR) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.38 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.34) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -84.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 61.62% during the next five years compared to 11.01% growth over the previous five years of trading.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Check out the current performance indicators for Capricor Therapeutics Inc (CAPR). In the past quarter, the stock posted a quick ratio of 4.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 25.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Analysing the last 5-days average volume posted by the [Capricor Therapeutics Inc, CAPR], we can find that recorded value of 1.43 million was lower than the volume posted last year of 1.91 million. As of the previous 9 days, the stock’s Stochastic %D was 85.81%.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 18.03%, which indicates a significant decrease from 65.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.49 in the past 14 days, which was lower than the 0.82 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.04, while its 200-day Moving Average is $10.66. Now, the first resistance to watch is $7.78. This is followed by the second major resistance level at $8.20. The third major resistance level sits at $8.47. If the price goes on to break the first support level at $7.09, it is likely to go to the next support level at $6.82. Should the price break the second support level, the third support level stands at $6.40.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
There are currently 45,717K shares outstanding in the company with a market cap of 336.48 million. Presently, the company’s annual sales total 22,270 K according to its annual income of -40,470 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,390 K.
